Thus, Sirt3 silencing seems to be beneficial in oral and esophageal carcinomas, where it protects cells from death, while in lung, colon, breast carcinomas the role of Sirt3 is not clear, and its suppression could have protumor effect. The gene discussed is SIRT3; the disease is breast carcinoma.